CardieX June Quarterly Appendix 4C

Cardiex Limited (ASX:CDX) is pleased to present its quarterly cash flow report for entities subject to Listing Rule 4.7B. Click here for the

CLEO Selects U.S. Clinical Trial Sites

MELBOURNE, AUSTRALIA, 31 July 2024: Ovarian cancer diagnostics company, Cleo Diagnostics Limited (ASX:COV) (CLEO, or the Company) is pleased to announce progress